Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Untreated Follicular Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02689869
What this trial is testing

Combination of PCI-32765 With Obinutuzumab in Untreated Follicular Lymphoma

Who this might be right for
Indolent Non-Hodgkin Lymphoma
Ludwig-Maximilians - University of Munich 98
Early research (Phase 1)Study completedNCT00003331
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
NYU Langone Health 30
Early research (Phase 1)Looking for participantsNCT07278856
What this trial is testing

Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas

Who this might be right for
Follicular Helper T-Cell LymphomaFollicular Helper T-Cell Lymphoma, Angioimmunoblastic-TypeFollicular Helper T-Cell Lymphoma, Follicular-Type+3 more
City of Hope Medical Center 20
Not applicableNot Yet RecruitingNCT07664787
What this trial is testing

Safety and Efficacy of Renal Denervation for Untreated Grade I Hypertension: a Pilot Study

Who this might be right for
HypertensionGrade 1
Ruijin Hospital 20
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Early research (Phase 1)Active Not RecruitingNCT01829568
What this trial is testing

Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma

Who this might be right for
Ann Arbor Stage II Grade 1 Contiguous Follicular LymphomaAnn Arbor Stage II Grade 1 Non-Contiguous Follicular LymphomaAnn Arbor Stage II Grade 2 Contiguous Follicular Lymphoma+9 more
National Cancer Institute (NCI)
Not applicableWithdrawnNCT00900120
What this trial is testing

Collecting and Storing Blood Samples From Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Study completedNCT05169658
What this trial is testing

Mosunetuzumab With or Without Polatuzumab Vedotin and Obinutuzumab for the Treatment of Untreated Indolent B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin LymphomaGrade 1 Follicular LymphomaGrade 2 Follicular Lymphoma+5 more
University of Washington 42
Testing effectiveness (Phase 2)Looking for participantsNCT07299149
What this trial is testing

Zanubrutinib, Obinutuzumab Combined With Lenalidomide (ZGR) for the Treatment of Untreated Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 34
Testing effectiveness (Phase 2)Study completedNCT00002553
What this trial is testing

Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphoma
Fred Hutchinson Cancer Center 50
Early research (Phase 1)Study completedNCT01588015
What this trial is testing

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+123 more
City of Hope Medical Center 36
Testing effectiveness (Phase 2)Study completedNCT02677155
What this trial is testing

Sequential Intranodal Immunotherapy (SIIT) Combined With Anti-PD1 (Pembrolizumab) in Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Oslo University Hospital 10
Testing effectiveness (Phase 2)Study completedNCT00002504
What this trial is testing

Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Hoag Memorial Hospital Presbyterian
Not applicableActive Not RecruitingNCT00935090
What this trial is testing

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Barbara Ann Karmanos Cancer Institute
Large-scale testing (Phase 3)Study completedNCT00006083
What this trial is testing

Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter

Who this might be right for
Cervical CancerChronic Myeloproliferative DisordersLeukemia+6 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT04450173
What this trial is testing

Obinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular Lymphoma

Who this might be right for
Ann Arbor Stage II Follicular LymphomaAnn Arbor Stage III Follicular LymphomaAnn Arbor Stage IV Follicular Lymphoma+3 more
University of California, Davis 40
Testing effectiveness (Phase 2)Study completedNCT00509184
What this trial is testing

Rituximab and Involved Field Radiotherapy in Early Stage Follicular Lymphoma

Who this might be right for
Lymphoma, Malignant
Klaus Herfarth, MD 85
Large-scale testing (Phase 3)Active Not RecruitingNCT06097364
What this trial is testing

A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma

Who this might be right for
Follicular Lymphoma (FL)
Regeneron Pharmaceuticals 733
Testing effectiveness (Phase 2)Study completedNCT02532257
What this trial is testing

Ibrutinib in Combination With Rituximab and Lenalidomide in Treating Patients With Previously Untreated, Stage II-IV Follicular Lymphoma or Marginal Zone Lymphoma

Who this might be right for
Ann Arbor Stage II Follicular LymphomaAnn Arbor Stage II Marginal Zone LymphomaAnn Arbor Stage III Follicular Lymphoma+7 more
M.D. Anderson Cancer Center 48
Large-scale testing (Phase 3)Study completedNCT00750009
What this trial is testing

Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Case Comprehensive Cancer Center 583
Next Page
33